Prof. Dr. MSc. Ph.D. Tobias Dreischulte

Institut für Allgemeinmedizin, Klinikum der Ludwig-Maximilians-Universität München

Professor für Klinische Versorgungsforschung (W2)

Pharmakoepidemiologie; Entwicklung und Evaluation von Interventionen zur Verbesserung der Pharmakotherapie in der ambulanten Versorgung

• 2013 MSc (with distinction) in Pharmacoepidemiology, EU2P consortium of 7 European Universities led by University of Bordeaux
  
• 2012 PhD in Clinical Pharmacy, University of Strathclyde, Glasgow, UK
  
• 2005 MSc (with distinction) in Clinical Pharmacy, University of Strathclyde, Glasgow, UK
  
• 2001 3.Staatsexamen Pharmazie, Universität Bonn
  
• 2000 2.Staatsexamen Pharmazie, Universität Bonn
  

• Seit 2019 W2 Professor für klinische Versorgungsforschung; Institut für Allgemeinmedizin, Klinikum der Ludwig-Maximilians-Universität München
  
• 2014 – 2019 Senior Lecturer, NHS Tayside/University of Dundee, UK
  
• 2009 – 2014 Research fellow, NHS Tayside/University of Dundee, UK
  

• Deutsche Gesellschaft für Versorgungsforschung
  
• European Society of Clinical Pharmacy
  
• Deutsche Gesellschaft für Allgemein- und Familienmedizin
  
• Deutsche Pharmazeutische Gesellschaft
  
• Netzwerk Evidenzbasierte Medizin
  

• 2017 Royal College of General Practitioners: Paper of the year award (Category winner Health Services Research)
  
• 2016 Scottish Health Awards Innovation category finalist
  
• 2014 International Primary Care Research Leadership Programme, University of Dundee/University of Oxford
  

1. Mair A, Wilson M, Dreischulte T. Addressing the Challenge of Polypharmacy. Annual review of pharmacology and toxicology. 2020;60:661-81.
   
2. Dreischulte T, Grant A, Hapca A, Guthrie B. Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: quantitative examination of variation between practices in recruitment, implementation and effectiveness. BMJ open. 2018;8(1):e017133.
   
3. Grant A, Dreischulte T, Guthrie B. Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: case study evaluation of adoption and maintenance of a complex intervention to reduce high-risk primary care prescribing. BMJ open. 2017;7(3):e015281.
   
4. Grant A, Dreischulte T, Guthrie B. Process evaluation of the data-driven quality improvement in primary care (DQIP) trial: active and less active ingredients of a multi-component complex intervention to reduce high-risk primary care prescribing. Implementation science : IS. 2017;12(1):4.
   
5. Guthrie B, Yu N, Murphy D, Donnan PT, Dreischulte T. Health Services and Delivery Research. Measuring prevalence, reliability and variation in high-risk prescribing in general practice using multilevel modelling of observational data in a population database. Southampton (UK): NIHR Journals Library
   
6. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC medicine. 2015;13:74.
   
7. Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney international. 2015;88(2):396-403.
   
8. Grant AM, Guthrie B, Dreischulte T. Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ open. 2014;4(1):e004153.
   
9. Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:15.
   
10. Dreischulte T, Grant AM, McCowan C, McAnaw JJ, Guthrie B. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC clinical pharmacology. 2012;12:5.
    
11. Dreischulte T, Grant A, Donnan P, McCowan C, Davey P, Petrie D, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implementation science : IS. 2012;7:24.
    
12. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. Bmj. 2011;342:d3514.